TY - JOUR
T1 - Surgery and neurointervention for intracranial atherosclerotic steno-occlusive disease
AU - Amin-Hanjani, Sepideh
AU - Yu, Simon Chun Ho
AU - Charbel, Fady
AU - Inamasu, Joji
AU - Kato, Yoko
AU - Wong, George Kwok Chu
PY - 2013
Y1 - 2013
N2 - Neurosurgeons and neurointerventionists interested in cerebral revascularisation to prevent stroke from intracranial atherosclerotic steno-occlusive disease were disappointed in 2011 with the closure of two important negative studies: the Carotid Occlusion Surgery Study (COSS) and Stenting and Aggressive Medical Therapy for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) study. Debates are centred on what causes these failures. While extracranial-intracranial (EC-IC) bypass and neurointervention (angioplasty and/ or stenting) cannot be considered a routine intervention for patients presenting with initial ischaemic event in the setting of atherosclerotic steno-occlusive disease, selected patients with severe haemodynamic impairment and/or recurrent symptoms despite maximal medical therapy may still benefit from surgery and neurointervention at high-volume centres, which can offer the procedure with low perioperative morbidity.
AB - Neurosurgeons and neurointerventionists interested in cerebral revascularisation to prevent stroke from intracranial atherosclerotic steno-occlusive disease were disappointed in 2011 with the closure of two important negative studies: the Carotid Occlusion Surgery Study (COSS) and Stenting and Aggressive Medical Therapy for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) study. Debates are centred on what causes these failures. While extracranial-intracranial (EC-IC) bypass and neurointervention (angioplasty and/ or stenting) cannot be considered a routine intervention for patients presenting with initial ischaemic event in the setting of atherosclerotic steno-occlusive disease, selected patients with severe haemodynamic impairment and/or recurrent symptoms despite maximal medical therapy may still benefit from surgery and neurointervention at high-volume centres, which can offer the procedure with low perioperative morbidity.
UR - http://www.scopus.com/inward/record.url?scp=84893130403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893130403&partnerID=8YFLogxK
U2 - 10.17925/ENR.2013.08.02.170
DO - 10.17925/ENR.2013.08.02.170
M3 - Article
AN - SCOPUS:84893130403
SN - 1758-3837
VL - 8
SP - 170
EP - 174
JO - European Neurological Review
JF - European Neurological Review
IS - 2
ER -